User profiles for "author:M John"

Mike T John

- Verified email at umn.edu - Cited by 20877

Melissa-Sue John

- Verified email at usj.edu - Cited by 3008

[HTML][HTML] Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD …

E Schiffman, R Ohrbach, E Truelove… - Journal of oral & …, 2014 - ncbi.nlm.nih.gov
Aims The original Research Diagnostic Criteria for Temporomandibular Disorders
(RDC/TMD) Axis I diagnostic algorithms have been demonstrated to be reliable. However …

Biofibres and biocomposites

MJ John, S Thomas - Carbohydrate polymers, 2008 - Elsevier
This review deals with a recent study of the literature on the various aspects of cellulosic
fibres and biocomposites. Cellulosic fibre reinforced polymeric composites are finding …

Fatty acid trophic markers in the pelagic marine environment

J Dalsgaard, MS John, G Kattner, D Müller-Navarra… - 2003 - Elsevier
Fatty acids have been used as qualitative markers to trace or confirm predator prey
relationships in the marine environment for more than thirty years. More recently, they have …

[HTML][HTML] Performance of the LHCb RICH detector at the LHC

…, T Hampson, N Harnew, D Hill, P Hunt, M John… - The European Physical …, 2013 - Springer
The LHCb experiment has been taking data at the Large Hadron Collider (LHC) at CERN
since the end of 2009. One of its key detector components is the Ring-Imaging Cherenkov …

[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …

…, K Spellman, K McCluggage, M John… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background The SARS-CoV-2 delta (B. 1.617. 2) variant was first detected in
England in March, 2021. It has since rapidly become the predominant lineage, owing to high …

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

…, S Elbashir, A Geick, P Hadwiger, J Harborth, M John… - Nature, 2004 - nature.com
RNA interference (RNAi) holds considerable promise as a therapeutic approach to silence
disease-causing genes, particularly those that encode so-called 'non-druggable'targets that …

RNAi-mediated gene silencing in non-human primates

…, MN Fedoruk, J Harborth, JA Heyes, LB Jeffs, M John… - Nature, 2006 - nature.com
The opportunity to harness the RNA interference (RNAi) pathway to silence disease-causing
genes holds great promise for the development of therapeutics directed against targets that …

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

…, M Jayaraman, M John… - Nature …, 2008 - nature.com
The safe and effective delivery of RNA interference (RNAi) therapeutics remains an
important challenge for clinical development. The diversity of current delivery materials …

[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

…, J Maksimovic, K Spellman, K McCluggage, M John… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …

[HTML][HTML] Investigating variation in replicability

RA Klein, KA Ratliff, M Vianello… - Social …, 2014 - econtent.hogrefe.com
Although replication is a central tenet of science, direct replications are rare in psychology.
This research tested variation in the replicability of 13 classic and contemporary effects …